Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Observation of the Vero Cell-derived Inactivated Japanese Encephalitis Vaccine (JEV-I) Given With Primary Immunization in a Large Amount of Healthy Children Aged 8 Months and Older

NCT06372665 is registered in ClinicalTrials.gov with Liaoning Chengda Biotechnology CO., LTD as lead sponsor.

NCT NCT06372665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06372665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Observation of the Vero Cell-derived Inactivated Japanese Encephalitis Vaccine (JEV-I) Given With Primary Immunization in a Large Amount of Healthy Children Aged 8 Months and Older
Lead sponsor
Liaoning Chengda Biotechnology CO., LTD
Phase
Observational
Overall status
Completed
Start date
January 1, 2024
Completion date
April 30, 2025
Enrollment
15,357 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis